Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perou

Showing results (291-300 of 476) with videos related to

Pageof 48
Sort By:
Radiology|May 5, 2016
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene AssaysHui Li, Yitan Zhu, Elizabeth S Burnside, et al.
Science Translational Medicine|June 9, 2017
Combined immune checkpoint blockade as a therapeutic strategy for <i>BRCA1</i>-mutated breast cancerEmma Nolan, Peter Savas, Antonia N Policheni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancerDezheng Huo, Francis Ikpatt, Andrey Khramtsov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
MYC is amplified in BRCA1-associated breast cancersTatyana A Grushko, James J Dignam, Soma Das, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2018
DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancerRyoichi Matsunuma, Doug W Chan, Beom-Jun Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinomaTorsten O Nielsen, Forrest D Hsu, Kristin Jensen, et al.
Breast Cancer Research and Treatment|February 26, 2014
Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) culturesKatherine Drews-Elger, Joeli A Brinkman, Philip Miller, et al.
Nature Genetics|July 1, 1996
Identification of the murine beige gene by YAC complementation and positional cloningC M Perou, K J Moore, D L Nagle, et al.
Cancer Cell|June 16, 2012
LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanomaWenjin Liu, Kimberly B Monahan, Adam D Pfefferle, et al.
Breast Cancer Research and Treatment|February 8, 2008
Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) programW F Anderson, S Luo, N Chatterjee, et al.
Pageof 48

Showing results (291-300 of 476) with videos related to

Sort By:
Pageof 48
Radiology|May 5, 2016
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene AssaysHui Li, Yitan Zhu, Elizabeth S Burnside, et al.
Science Translational Medicine|June 9, 2017
Combined immune checkpoint blockade as a therapeutic strategy for <i>BRCA1</i>-mutated breast cancerEmma Nolan, Peter Savas, Antonia N Policheni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancerDezheng Huo, Francis Ikpatt, Andrey Khramtsov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
MYC is amplified in BRCA1-associated breast cancersTatyana A Grushko, James J Dignam, Soma Das, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2018
DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancerRyoichi Matsunuma, Doug W Chan, Beom-Jun Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinomaTorsten O Nielsen, Forrest D Hsu, Kristin Jensen, et al.
Breast Cancer Research and Treatment|February 26, 2014
Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) culturesKatherine Drews-Elger, Joeli A Brinkman, Philip Miller, et al.
Nature Genetics|July 1, 1996
Identification of the murine beige gene by YAC complementation and positional cloningC M Perou, K J Moore, D L Nagle, et al.
Cancer Cell|June 16, 2012
LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanomaWenjin Liu, Kimberly B Monahan, Adam D Pfefferle, et al.
Breast Cancer Research and Treatment|February 8, 2008
Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) programW F Anderson, S Luo, N Chatterjee, et al.
Pageof 48